1. Home
  2. CRI vs QURE Comparison

CRI vs QURE Comparison

Compare CRI & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Carter's Inc.

CRI

Carter's Inc.

HOLD

Current Price

$39.57

Market Cap

1.2B

ML Signal

HOLD

Logo uniQure N.V.

QURE

uniQure N.V.

HOLD

Current Price

$25.11

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRI
QURE
Founded
1865
1998
Country
United States
Netherlands
Employees
N/A
248
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
2002
2013

Fundamental Metrics

Financial Performance
Metric
CRI
QURE
Price
$39.57
$25.11
Analyst Decision
Hold
Buy
Analyst Count
6
14
Target Price
$35.60
$45.00
AVG Volume (30 Days)
1.1M
2.0M
Earning Date
05-12-2026
05-05-2026
Dividend Yield
2.74%
N/A
EPS Growth
N/A
29.67
EPS
0.39
N/A
Revenue
$2,898,426,000.00
$13,107,000.00
Revenue This Year
$4.57
$126.12
Revenue Next Year
$1.12
$200.43
P/E Ratio
$98.05
N/A
Revenue Growth
1.91
N/A
52 Week Low
$23.38
$8.73
52 Week High
$44.44
$71.50

Technical Indicators

Market Signals
Indicator
CRI
QURE
Relative Strength Index (RSI) 63.81 59.18
Support Level $32.05 $22.59
Resistance Level $41.09 $25.66
Average True Range (ATR) 1.72 2.09
MACD 0.56 -0.35
Stochastic Oscillator 82.81 35.08

Price Performance

Historical Comparison
CRI
QURE

About CRI Carter's Inc.

Carter's Inc makes apparel for babies and children under brand names including Carter's and OshKosh B'gosh. It sells its products through a multi-channel business model, which includes retail stores, eCommerce, and wholesale sales channels, as well as retail omnichannel capabilities in the United States and Canada, which enables it to reach a broad range of consumers around the world. The company operates in three segments; U.S. Retail, U.S. Wholesale, and International. The majority of revenue is derived from U.S. Wholesale segment. The company predominantly sources products through contract manufacturers in Asia. It has multiple distribution centers in the U.S., in addition to distribution centers in Canada and Asia that serve international customers.

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.

Share on Social Networks: